Analyst Ratings for Thermo Fisher Scientific (TMO) [Buys]
TMO Rating Summary
TMO Price Target Summary
- Highest: $650.00 (UBS)
- Lowest: $475.00 (Wells Fargo)
- Average: $586.19
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$586.19 (+3.1%)
* Over Last 12-Mos
Rating Score: 8.1 / 10
Percentile Rank: 85%
Rating Score: 8.1 / 10
Percentile Rank: 85%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/25/2024 | CFRA | N/A | Upgrade | Buy (Hold) |
635.00 (522.00) |
583.09 (568.72) |
-2.46% | Details |
| 1/29/2024 | Nephron | Jack Meehan | Upgrade | Buy (Hold) |
N/A (N/A) |
547.33 (568.72) |
3.91% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
